The Ventriloquist Puppet Method for Children Under The Inhaler Treatment
NCT ID: NCT06162598
Last Updated: 2024-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2023-08-12
2024-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inhalation Treatment Distraction in Children
NCT06874491
Effect of Inhalation Therapy on Children's Fear and Anxiety Levels and Physiological Parameters
NCT06486610
The Effect of Watching Informative Animation on Fear and Anxiety in Children
NCT05861232
Virtual Reality Application During High Flow Nasal Oxygen Therapy in Children Effect on Anxiety Levels
NCT06886828
Augmented Reality Applied Book Reading in the Preoperative Period
NCT06399016
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Children in the control group will undergo the routine preparation procedure applied in the emergency department. Before and after inhaler treatment, the child, parent, and nurse will be asked to fill out data collection forms to assess the child's anxiety and fear levels.
No interventions assigned to this group
Ventriloquist Puppet group
The preparation for the procedure will be accompanied by a puppet before the treatment. The child will be told about the features of the puppet and will be introduced to it. The inhaler treatment application will be explained to the intervention group through the ventriloquist puppet method. By making the puppet talk using the ventriloquism technique, the child will be able to understand the procedure. The application of the inhaler will be shown to the child with the help of a nebulizer mask on the puppet. Before the application and after the inhaler treatment, the child, parent, and nurse will be asked to fill out the children's state anxiety scale and children's fear scale to evaluate the child's anxiety and fear levels.
Ventriloquist Puppet
one day preparation intervention applied by researcher for children under the inhaler treatment. Preparation will be 30 minutes long
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ventriloquist Puppet
one day preparation intervention applied by researcher for children under the inhaler treatment. Preparation will be 30 minutes long
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children receiving inhaler therapy,
* Children and families who can speak Turkish,
* Children and families who volunteer to participate in the research,
Exclusion Criteria
* Children with life-threatening conditions,
* Children with hearing, vision and/or speech impairments
4 Years
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karamanoğlu Mehmetbey University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tuba Arpacı
Asisstant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tuba ARPACI, PhD
Role: PRINCIPAL_INVESTIGATOR
Karamanoğlu Mehmetbey University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tuba ARPACI
Karaman, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KMU-SBF-TA-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.